WorldQuant Millennium Advisors
RARE icon

WorldQuant Millennium Advisors’s Ultragenyx Pharmaceutical RARE Stock Holding History

WorldQuant Millennium Advisors’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.16M Buy
214,374
+63,787
+42% +$1.58M 0.02% 350
2026
Q1 		$3.15M Buy
150,587
+53,679
+55% +$1.21M 0.01% 380
2025
Q4 		$2.23M Buy
+96,908
New +$3.19M 0.01% 418

Other funds holding RARE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

WorldQuant Millennium Advisors's RARE Position: Q2 2026 in Review

WorldQuant Millennium Advisors increased its Ultragenyx Pharmaceutical (RARE) stake by 42% in Q2 2026, buying an estimated $1.58M and bringing the position to 214,374 shares worth $7.16M. The position accounts for 0.02% of the portfolio, ranked #350.

WorldQuant Millennium Advisors first reported a position in RARE in Q4 2025 and has held it in 3 quarters since. 311 funds tracked by Wall St. Rank hold RARE as of Q2 2026.

  • WorldQuant Millennium Advisors held 214,374 shares of Ultragenyx Pharmaceutical worth $7.16M as of Q2 2026.
  • WorldQuant Millennium Advisors bought 63,787 Ultragenyx Pharmaceutical shares in Q2 2026, an estimated $1.58M.
  • Ultragenyx Pharmaceutical made up 0.02% of WorldQuant Millennium Advisors's portfolio in Q2 2026, its #350 holding.
  • WorldQuant Millennium Advisors first reported a position in Ultragenyx Pharmaceutical in Q4 2025 and has held it in 3 quarters since.
  • 311 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2026.

Based on WorldQuant Millennium Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.